A carregar...

Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial

The only causative treatment for IgE-mediated allergies is allergen-specific immunotherapy. However, fewer than 5% of allergy patients receive immunotherapy because of its long duration and risk of allergic side effects. We aimed at enhancing s.c. immunotherapy by direct administration of allergen i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Senti, Gabriela, Prinz Vavricka, Bettina M., Erdmann, Iris, Diaz, Mella I., Markus, Richard, McCormack, Stephen J., Simard, John J., Wüthrich, Brunello, Crameri, Reto, Graf, Nicole, Johansen, Pål, Kündig, Thomas M.
Formato: Artigo
Idioma:Inglês
Publicado em: National Academy of Sciences 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2582048/
https://ncbi.nlm.nih.gov/pubmed/19001265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0803725105
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!